Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2026-01-09 @ 7:44 PM
Study NCT ID:
NCT00715702
Status:
COMPLETED
Last Update Posted:
2009-04-29
First Post:
2008-07-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of AZD5672 in Renally Impaired Subjects
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D1710C00020
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Mark Layton, MD, PhD, Medical Science Director
Old Organization:
AstraZeneca R&D Alderely Park